SNEHA MATHEW: Open Payments
NPI 1467962787 · PEARSALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 47 payments from 13 companies in 2025. Trend: 2023 $759 · 2024 $1,061 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $217 |
| GlaxoSmithKline, LLC. | 10 | $151 |
| PFIZER INC. | 5 | $109 |
| Abbott Laboratories | 4 | $86 |
| Corcept Therapeutics | 3 | $74 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Almatica Pharma LLC | 1 | $28 |
Products named: MOUNJARO, TRELEGY ELLIPTA, PREVNAR 20, FREESTYLE LIBRE 3, Korlym, JARDIANCE, AIRSUPRA, SHINGRIX.
Industry payments across TX — which companies pay providers there.
